Plant pigment can significantly reduce blood pressure

Plant pigment can significantly reduce blood pressure

by Oxford University Press Credit: CC0 Public Domain A new paper in Nutrition Reviews finds that intake of the flavonoid quercetin can greatly reduce high blood pressure in patients suffering from cardiovascular disease. Researchers here consulted multiple studies that assessed the impact of quercetin on blood pressure and glucose levels. Quercetin is a plant pigment commonly found in many plants and foods, such as onions, teas, apples and red wine. Each study utilized here assessed blood glucose, total cholesterol, and/or insulin. 17 studies with a total of 886 participants were included. The pooled result from 13 treatment arms throughout the studies consulted showed that quercetin administration markedly reduced systolic blood pressure . Participants who consumed quercetin for eight weeks or more showed significantly changed levels of high-density lipoprotein cholesterol. Quercetin did not markedly influence total cholesterol, or significantly alter fasting blood glucose concentrations. Quercetin was not found to cause serious adverse events in any of the included studies. The review concluded that a reduction in blood pressure of more than 10 mmHg lowers cardiovascular risk by 50% for heart failure, 35% - 40% for stroke, and approximately 20% to 25% for myocardial infarction. Researchers here found that the favorable effects of quercetin on blood pressure support the use of quercetin for patients with hypertension. Explore further



Also in Industry News

How to decide whether or not to start treatment for prostate cancer?
How to decide whether or not to start treatment for prostate cancer?

0 Comments

How to decide whether or not to start treatment for prostate cancer?

Read More

Analysis of the SARS-CoV-2 proteome via visual tools
Analysis of the SARS-CoV-2 proteome via visual tools

0 Comments

Analysis of the SARS-CoV-2 proteome via visual tools

Read More

$65m investment increases British Patient Capital’s exposure to life sciences and health technology
$65m investment increases British Patient Capital’s exposure to life sciences and health technology

0 Comments

$65m investment increases British Patient Capital’s exposure to life sciences and health technology

Read More